Clinigence Holdings (NUTX) Price & Analysis

Compare

363 Followers

NUTX Stock Chart & Stats

$111.00

-$1.17(-3.51%)

At close: Jan 08 4:00 PM EST

$111.00

-$1.17(-3.51%)

Day’s Range― - ―

52-Week Range$28.12 - $184.28

Previous CloseN/A

Volume3.28K

Average Volume (3M)149.02K

Market Cap

$797.71M

Enterprise ValueN/A

Total Cash (Recent Filing)$166.05M

Total Debt (Recent Filing)$358.60M

Price to Earnings (P/E)5.9

Beta2.04

Next Earnings

Mar 26, 2026

EPS Estimate

3.19

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding7,071,916

10 Day Avg. Volume239,717

30 Day Avg. Volume149,024

Financial Highlights & Ratios

PEG Ratio-0.02

Price to Book (P/B)1.10

Price to Sales (P/S)0.34

P/FCF Ratio7.75

Enterprise Value/Market Cap0.00

Enterprise Value/Revenue0.00

Enterprise Value/Gross Profit0.00

Enterprise Value/Ebitda0.00

Forecast

1Y Price Target

$265.00

Price Target Upside138.74% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Expansion PlansNutex reopened a micro-hospital in Red River, Texas, and plans to open 5-6 additional de novo micro-hospitals by the end of 2026.

Financial StabilityNutex has sufficient capital to maintain current operations and advance expansion plans, with cash of $96.4M and debt of $35.5M as of June 30, 2025.

Revenue GrowthNutex Health Inc. reported revenue and GAAP EPS significantly above consensus and estimates, with revenue up 240%.

Bears Say

Accounting IssuesNutex filed an NT 10-Q notification of inability to timely file its 10-Q due to the incorrect accounting classification of certain non-cash obligations, leading to the need for restatements.

Legal ChallengesPotential headwinds to NUTX's stock price include accounting restatements, arbitration dynamics, and lawsuits against Nutex's primary arbitration vendor, HaloMD.

Clinigence Holdings News

Nutex Health says ‘Capybara Research as an entity seems not to exist’

“Nutex Health (NUTX) is aware of a short seller report issued on November 25, 2025 by Capybara Research....

2d ago

NUTX

Capybara Research believes Nutex Health engaged in fraudulent business practices

Capybara Research said in a recently published report that it sees “problems at Nutex.” “Over a dozen Nutex...

3d ago

NUTX

Nutex Health reports Q3 EPS $7.76 vs. ($1.72) last year

Reports Q3 revenue $267.8M, consensus $213.81M. “We are continuing to add to a record year with 225% revenue...

9d ago

NUTX

Closing Bell Movers: Plug Power slips after converible notes offering

U.S. equity futures were slightly higher following sharp declines during the session, as investors digest a growing hang-up...

10d ago

CEG

CARV

Nutex Health reports Q3 revenue $244M, consensus $221.93M

“We are pleased to report 217.5% revenue growth, Adjusted EBITDA attributable to Nutex Health (NUTX) of $144.4 million,...

10d ago

NUTX

Clinigence Holdings Files Auditors’ Consent for Nutex

An announcement from Clinigence Holdings ( ($NUTX) ) is now available. Clinigence Holdings has filed an auditors’ consent...

4d ago

NUTX

Nutex Health Inc. Reports Strong Revenue Growth

Clinigence Holdings Inc ( ($NUTX) ) has released its Q3 earnings. Here is a breakdown of the information...

9d ago

NUTX

Nutex Health Delays Quarterly Report Filing

Clinigence Holdings ( ($NUTX) ) has released a notification of late filing. Nutex Health Inc. has announced a...

11d ago

NUTX

NUTX Lawsuit Alert! Class Action Lawsuit Against Nutex Health

A class action lawsuit was filed against Nutex Health ($NUTX) on August 22, 2025. The plaintiffs (shareholders) alleged that they bought...

1M ago

NUTX

Clinigence Holdings Granted Extension for Nasdaq Compliance

An announcement from Clinigence Holdings ( ($NUTX) ) is now available. On August 20, 2025, Clinigence Holdings received...

1M ago

NUTX

Nutex Health reports Q3 estimated patient volume $46.29M, up 11.1%

Reports Q3 estimated cash collections $235M, up 258.8%. The third quarter saw patient volumes rise 11.1% compared to...

1M ago

NUTX

Nutex Health Appoints New Chief Operating Officer

Clinigence Holdings ( ($NUTX) ) has issued an update. On September 22, 2025, Nutex Health Inc. announced the...

2M ago

NUTX

Nutex Health appoints Wesley Bamburg as COO

Nutex Health (NUTX) announced the appointment of Wesley Bamburg as the company’s COO, effective October 13. Bamburg has...

2M ago

HCA

NUTX

Clinigence Holdings Faces Derivative Action Lawsuit

Clinigence Holdings ( ($NUTX) ) has provided an update. On September 8, 2025, a derivative action was filed...

3M ago

NUTX

NUTX FAQ

What was Clinigence Holdings Inc’s price range in the past 12 months?

Clinigence Holdings Inc lowest stock price was $28.12 and its highest was $184.28 in the past 12 months.

What is Clinigence Holdings Inc’s market cap?

Clinigence Holdings Inc’s market cap is $797.71M.

When is Clinigence Holdings Inc’s upcoming earnings report date?

Clinigence Holdings Inc’s upcoming earnings report date is Mar 26, 2026 which is in 118 days.

How were Clinigence Holdings Inc’s earnings last quarter?

Currently, no data Available

Is Clinigence Holdings Inc overvalued?

According to Wall Street analysts Clinigence Holdings Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Clinigence Holdings Inc pay dividends?

Clinigence Holdings Inc does not currently pay dividends.

What is Clinigence Holdings Inc’s EPS estimate?

Clinigence Holdings Inc’s EPS estimate is 3.19.

How many shares outstanding does Clinigence Holdings Inc have?

Clinigence Holdings Inc has 7,071,916 shares outstanding.

What happened to Clinigence Holdings Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Clinigence Holdings Inc?

Currently, no hedge funds are holding shares in NUTX

Clinigence Holdings Stock Smart Score

Outperform

Fundamentals

Return on Equity

63.86%

Trailing 12-Months

Asset Growth

119.96%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Clinigence Holdings Inc

Clinigence Holdings (NUTX) is a healthcare technology company that focuses on providing innovative solutions for data management, analytics, and health information exchange. Operating primarily within the healthcare sector, Clinigence aims to enhance the quality of care and operational efficiency for healthcare providers through its advanced software platforms and services. The company's offerings include population health management tools, electronic health record (EHR) systems, and data analytics services that assist providers in improving patient outcomes and optimizing their operations.

Clinigence Holdings (NUTX) Earnings & Revenues

Historic Earnings Reports

NUTX Stock 12 Month Forecast

Average Price Target

$265.00

▲(138.74% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"$20","301":"$301","90.25":"$90.3","160.5":"$160.5","230.75":"$230.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$300.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":265,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$265.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":230,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$230.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,90.25,160.5,230.75,301],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,123.06,136.67076923076922,150.28153846153847,163.8923076923077,177.50307692307692,191.11384615384617,204.7246153846154,218.3353846153846,231.94615384615383,245.55692307692308,259.1676923076923,272.77846153846156,286.3892307692308,{"y":300,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,123.06,133.97846153846154,144.8969230769231,155.81538461538463,166.73384615384617,177.65230769230772,188.57076923076923,199.48923076923077,210.40769230769232,221.32615384615386,232.2446153846154,243.16307692307691,254.08153846153846,{"y":265,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,123.06,131.28615384615384,139.5123076923077,147.73846153846154,155.9646153846154,164.19076923076923,172.41692307692307,180.64307692307693,188.86923076923077,197.0953846153846,205.32153846153847,213.5476923076923,221.77384615384614,{"y":230,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":21.39,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.6,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.58,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.69,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.63,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.4,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":117.99,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.8,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.92,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":104.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.06,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >